Current position:Home >Product >
10-(4-Cyclohexyl-benzoyl)-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxamide
10-(4-Cyclohexyl-benzoyl)-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxamide(473911-68-1)
- Name: 10-(4-Cyclohexyl-benzoyl)-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxamide
- Synonyms:
- Molecular Formula:
- Molecular Weight:524.706
- CAS Registry Number:473911-68-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 473303-64-9/1-(3-methylphenyl)-5-[3,6-difluoro-4-(methylsulfonyl)phenyl]-3-(difluoromethyl)-1H-pyrazole
- 531551-73-2/2-(5-{[(3-chloro-2-methylphenyl)sulfonyl]amino}-1,2,4-thiadiazol-3-yl)-N,N-dipropylacetamide
- 531552-37-1/N-[3-(2-morpholin-4-yl-2-oxoethyl)-1,2,4-thiadiazol-5-yl]-4-pyridin-4-ylbenzenesulfonamide
- 459450-24-9/5-(2-Pyrrolidino-ethyl)-2-methyl-1H-indole-3-carboxylic acid-1-(2-chlorophenyl)-ethyl ester
- 473300-65-1/1-(3-methyl-4-fluorophenyl)-5-[3,5-difluoro-4-(methylsulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazole
- 290351-87-0/N-[4-(3-benzenesulfonyl-4-hydroxy-phenoxy)-3,5-dichloro-phenyl]-oxamic acid
- 439225-80-6/5-[5-(Allyl-methyl-amino)-pentyl]-2,3-dihydro-indole-1-sulfonic acid (4-chloro-phenyl)-amide
- 503168-35-2/(3S,4S)-4-{[4-(2,3-dihydro-4H-1,4-benzothiazin-4-ylmethyl)benzoyl]amino}-N-hydroxy-3-pyrrolidinecarboxamide
- 503167-82-6/(3S,4S)-4-({4-[(1,2-dimethyl-1H-indol-3-yl)methyl]benzoyl}amino)-N-hydroxy-3-pyrrolidinecarboxamide
- 489466-72-0/4-[[4-(4-Chloro-phenyl)-3,5-dimethyl-pyrazol-1-yl]-(3-hydroxy-phenyl)-methyl]-N,N-diethyl-benzamide
- 477252-24-7/N-cyclopropyl-1-{3-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]phenyl}-1,4-dihydro[1,8]naphthyridin-4-one-3-carboxamide
- 410545-48-1/N-[4-fluoro-2-(methylthio)benzyl]-8-hydroxy-5-{methyl[(1-methyl-1H-imidazol-4-yl)sulfonyl]amino}-1,6-naphthyridine-7-carboxamide
- 847022-84-8/1-[5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl]-3-[4-(3-methanesulfonylphenyl)naphthalen-1-yl]-urea
- 503167-29-1/tert-butyl (3S,4S)-3-[(hydroxyamino)carbonyl]-4-({4-[(2-methyl-6-nitro-1H-benzimidazol-1-yl)methyl]benzoyl}amino)-1-pyrrolidinecarboxylate
- 473911-68-1/10-(4-Cyclohexyl-benzoyl)-N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-10,11-dihydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-3-carboxamide
- 476010-88-5/N-[5-tert-Butyl-2-methoxy-3-(3-{4-[2-(2-methoxy-1-methyl-ethylamino)-pyrimidin-4-yloxy]-naphthalen-1-yl}-ureido)-phenyl]-methanesulfonamide
- 488848-09-5/N-{(1S,2R)-1-(3,5-difluorobenzyl)-3-[(3-ethylbenzyl)amino]-2-hydroxypropyl}-2-[(5R)-5-ethyl-2,3-dioxo-4-propylpiperazin-1-yl]acetamide
- 351490-72-7/(R)-3-(4-cyano-3-(3-(1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-ylamino)-2-hydroxypropoxy)phenyl)propanoic acid hydrochloride
- 259732-46-2/8-[1-(2,6-dimethylphenyl)ethylamino]-2,3-dimethylimidazo[1,2-a]pyridine
- 333987-66-9/4-[4-(1-Pyrrolidinylsulfonyl)benzyl]piperidine
- 333988-01-5/1-Acetyl-4-[4-(cyclopentylsulfanyl)benzyl]piperidine
- 244152-55-4/2-(3-(2-(5-methyl-2-cyclopentyloxazol-4-yl)ethoxy)phenyl)acetic acid
- 327985-52-4/3-cyclopentyl-5-ethyl-2-(2-ethyl-2H-[1,2,4]triazol-3-ylmethoxy)-8-phenylimidazo[1,2-d][1,2,4]triazine
- 1138912-16-9/{4-[2-(5,5-dimethyl-[1,3]dioxan-2-yl)-5-(4-fluoro-phenyl)-3H-imidazol-4-yl]-pyrimidin-2-ylamino}-acetic acid
- 298698-35-8/N-{2-[4-(3,4-Dichlorophenoxy)-1-piperidinyl]ethyl}-2-(4-pyridinyl)-1,3-thiazole-4-carboxamide
- 327985-54-6/3-cyclopentyl-5-cyclopropyl-2-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-8-phenylimidazo[1,2-d][1,2,4]triazine
- 313045-92-0/2-Phenylamino-3-[4-[2-(4-pyridine-2-ylbenzoylamino)ethoxy]phenyl]propionic acid
- 239069-18-2/2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(3,4-difluorophenyl)-1H-[1]benzopyrano[3,4-f]quinoline
- 216874-24-7/trans-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-ethyl-(3-isopropenylbenzyl)amine Hydrochloride
- 312300-01-9/N-((2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl)-1-methyl-N-(3,4,5-trimethoxyphenyl)-1H-indole-5-sulfonamide